Retaglutide is a innovative GLP-1 receptor agonist currently under study for the management of obesity. This medication works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://flynnusun023098.idblogmaker.com/37877304/retaglutide-a-promising-glp-1-receptor-agonist